Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Mouse mutagenesis and disease models for neuropsychiatric disorders.

Gondo Y, Murata T, Makino S, Fukumura R, Ishitsuka Y.

Curr Top Behav Neurosci. 2011;7:1-35. doi: 10.1007/7854_2010_106. Review.

PMID:
21298381
2.

Molecular genetic models related to schizophrenia and psychotic illness: heuristics and challenges.

O'Tuathaigh CM, Desbonnet L, Moran PM, Kirby BP, Waddington JL.

Curr Top Behav Neurosci. 2011;7:87-119. doi: 10.1007/7854_2010_111.

PMID:
21298380
3.

Animal models of epigenetic regulation in neuropsychiatric disorders.

Bountra C, Oppermann U, Heightman TD.

Curr Top Behav Neurosci. 2011;7:281-322. doi: 10.1007/7854_2010_104.

PMID:
21225415
5.

Animal models of neuropsychiatric disorders.

Nestler EJ, Hyman SE.

Nat Neurosci. 2010 Oct;13(10):1161-9. doi: 10.1038/nn.2647. Epub 2010 Sep 27. Review.

6.

Linking molecules to mood: new insight into the biology of depression.

Krishnan V, Nestler EJ.

Am J Psychiatry. 2010 Nov;167(11):1305-20. doi: 10.1176/appi.ajp.2009.10030434. Epub 2010 Sep 15. Review.

7.

Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens.

LaPlant Q, Vialou V, Covington HE 3rd, Dumitriu D, Feng J, Warren BL, Maze I, Dietz DM, Watts EL, Iñiguez SD, Koo JW, Mouzon E, Renthal W, Hollis F, Wang H, Noonan MA, Ren Y, Eisch AJ, Bolaños CA, Kabbaj M, Xiao G, Neve RL, Hurd YL, Oosting RS, Fan G, Morrison JH, Nestler EJ.

Nat Neurosci. 2010 Sep;13(9):1137-43. doi: 10.1038/nn.2619. Epub 2010 Aug 22.

8.

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.

Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS.

Science. 2010 Aug 20;329(5994):959-64. doi: 10.1126/science.1190287.

9.

Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance.

Lagace DC, Donovan MH, DeCarolis NA, Farnbauch LA, Malhotra S, Berton O, Nestler EJ, Krishnan V, Eisch AJ.

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4436-41. doi: 10.1073/pnas.0910072107. Epub 2010 Feb 22.

10.

Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice.

Kolber BJ, Boyle MP, Wieczorek L, Kelley CL, Onwuzurike CC, Nettles SA, Vogt SK, Muglia LJ.

J Neurosci. 2010 Feb 17;30(7):2571-81. doi: 10.1523/JNEUROSCI.4470-09.2010.

11.

Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior.

Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2669-74. doi: 10.1073/pnas.0910658107. Epub 2010 Jan 26.

12.

A beta3-adrenergic-leptin-melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress.

Chuang JC, Krishnan V, Yu HG, Mason B, Cui H, Wilkinson MB, Zigman JM, Elmquist JK, Nestler EJ, Lutter M.

Biol Psychiatry. 2010 Jun 1;67(11):1075-82. doi: 10.1016/j.biopsych.2009.12.003. Epub 2010 Jan 12. Erratum in: Biol Psychiatry. 2010 Jul 1;68(1):112. Cui, Huixing [corrected to Cui, Huxing].

13.

Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression.

Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE.

Biol Psychiatry. 2010 Jan 15;67(2):110-6. doi: 10.1016/j.biopsych.2009.09.013.

PMID:
19914605
14.

Dynamic DNA methylation programs persistent adverse effects of early-life stress.

Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmühl Y, Fischer D, Holsboer F, Wotjak CT, Almeida OF, Spengler D.

Nat Neurosci. 2009 Dec;12(12):1559-66. doi: 10.1038/nn.2436. Epub 2009 Nov 8. Erratum in: Nat Neurosci. 2010 May;13(5):649.

PMID:
19898468
15.

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ.

Biol Psychiatry. 2010 Jan 15;67(2):139-45. doi: 10.1016/j.biopsych.2009.08.038.

PMID:
19897179
16.

Developmental cascades linking stress inoculation, arousal regulation, and resilience.

Lyons DM, Parker KJ, Katz M, Schatzberg AF.

Front Behav Neurosci. 2009 Sep 18;3:32. doi: 10.3389/neuro.08.032.2009. eCollection 2009.

17.

Antidepressant actions of histone deacetylase inhibitors.

Covington HE 3rd, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ 3rd, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ.

J Neurosci. 2009 Sep 16;29(37):11451-60. doi: 10.1523/JNEUROSCI.1758-09.2009.

18.

Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats.

Vitale G, Ruggieri V, Filaferro M, Frigeri C, Alboni S, Tascedda F, Brunello N, Guerrini R, Cifani C, Massi M.

Psychopharmacology (Berl). 2009 Dec;207(2):173-89. doi: 10.1007/s00213-009-1646-9. Epub 2009 Aug 27.

PMID:
19711054
19.

A molecular signature of depression in the amygdala.

Sibille E, Wang Y, Joeyen-Waldorf J, Gaiteri C, Surget A, Oh S, Belzung C, Tseng GC, Lewis DA.

Am J Psychiatry. 2009 Sep;166(9):1011-24. doi: 10.1176/appi.ajp.2009.08121760. Epub 2009 Jul 15.

20.

Stress hormone regulation: biological role and translation into therapy.

Holsboer F, Ising M.

Annu Rev Psychol. 2010;61:81-109, C1-11. doi: 10.1146/annurev.psych.093008.100321. Review.

PMID:
19575614

Supplemental Content

Support Center